Modulation of immune system by Kaposi's sarcoma-associated herpesvirus: Lessons from viral evasion strategies

Frontiers in Microbiology

Volumn 3, Issue MAR, 2012, Pages

  Lee, Hye Ra ^a   Brulois, Kevin ^a   Wong, Lai Yee ^a   Jung, Jae U ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

KSHV; Modulation of immune system; Viral evasion strategies

Indexed keywords

EID: 84875680224     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2012.00044     Document Type: Article

References (182)

1. Abend, J. R., Uldrick, T., and Ziegel-bauer, J. M. (2010). Regulation of tumor necrosis factor-like weak inducer of apoptosis receptor protein (TWEAKR) expression by Kaposi's sarcoma-associated herpesvirus microRNA prevents TWEAK-induced apoptosis and inflammatory cytokine expression. J. Virol. 84, 12139-12151.
2. Akira, S., and Takeda, K. (2004). Toll-like receptor signalling. Nat. Rev. Immunol. 4,499-511.
3. Akira, S., Uematsu, S., and Takeuchi, O. (2006). Pathogen recognition and innate immunity. Cell 124, 783-801.
4. Alcami, A., and Koszinowski, U. H. (2000). Viral mechanisms of immune evasion. Trends Microbiol. 8,410-418.
5. Ambagala, A. P., Solheim, J. C., and Srikumaran, S. (2005). Viral interference with MHC class I antigen presentation pathway: the battle continues. Vet. Immunol. Immunopathol. 107, 1-15.
6. Aoki, Y., Jaffe, E. S., Chang, Y., Jones, K., Teruya-Feldstein, J., Moore, P. S., and Tosato, G. (1999). Angio-genesis and hematopoiesis induced by Kaposi's sarcoma-associated herpesvirus-encoded interleukin-6. Blood 93, 4034-4043.
7. Areste, C., Mutocheluh, M., and Black-bourn, D. J. (2009). Identification of caspase-mediated decay of inter-feron regulatory factor-3, exploited by a Kaposi sarcoma-associated herpesvirus immunoregulatory protein. J. Biol. Chem. 284,23272-23285.
8. Arico, S., Petiot, A., Bauvy, C., Dubbel-huis, P. F., Meijer, A. J., Codogno, P., and Ogier-Denis, E. (2001). The tumor suppressor PTEN positively regulates macroautophagy by inhibiting the phosphatidylinositol 3-kinase/protein kinase B pathway. J. Biol. Chem. 276, 35243-35246.
9. Bais, C., Van Geelen, A., Eroles, P., Mutlu, A., Chiozzini, C., Dias, S., Silverstein, R. L., Rafii, S., and Mesri, E. A. (2003). Kaposi's sarcoma associated herpesvirus G protein-coupled receptor immortalizes human endothelial cells by activation of the VEGF receptor-2/KDR. Cancer Cell 3, 131-143.
10. Bartel, D. P. (2004). MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116,281-297.
11. Bisson, S. A., Page, A. L., and Ganem, D. (2009). A Kaposi's sarcoma-associated herpesvirus protein that forms inhibitory complexes with type I interferon receptor subunits, Jak and STAT proteins, and blocks interferon-mediated signal trans-duction. J. Virol. 83, 5056-5066.
12. Blue, C. E., Spiller, O. B., and Black-bourn, D. J. (2004). The relevance of complement to virus biology. Virology 319, 176-184.
13. Bond, G. L., Hu, W., and Levine, A. J. (2005). MDM2 is a central node in the p53 pathway: 12 years and counting. Curr. Cancer Drug Targets 5, 3-8.
14. Bottero, V., Kerur, N., Sadagopan, S., Patel, K., Sharma-Walia, N., and Chandran, B. (2010). Phospho-rylation and polyubiquitination of transforming growth factor beta-activated kinase 1 are necessary for activation of NF-kappaB by the Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor. J. Virol. 85, 1980-1993.
15. Bubman, D., Guasparri, I., and Cesarman, E. (2007). Deregulation of c-Myc in primary effusion lymphoma by Kaposi's sarcoma herpesviruslatency-associated nuclear antigen. Oncogene 26, 4979-4986.
16. Burger, R., Neipel, F., Fleckenstein, B., Savino, R., Ciliberto, G., Kalden, J. R., and Gramatzki, M. (1998). Human herpesvirus type 8 interleukin-6 homologue is functionally active on human myeloma cells. Blood 91, 1858-1863.
17. Burysek, L., and Pitha, P. M. (2001). Latently expressed human herpesvirus 8-encoded interferon regulatory factor 2 inhibits double-stranded RNA-activated protein kinase. J. Virol. 75, 2345-2352.
18. Cannon, M. (2007). The KSHV and other human herpesviral G protein-coupled receptors. Curr. Top. Microbiol. Immunol. 312,137-156.
19. Cannon, M., Philpott, N. J., and Cesarman, E. (2003). The Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor has broad signaling effects in primary effusion lymphoma cells. J. Virol. 77, 57-67.
20. Cannon, M. L., and Cesarman, E. (2004). The KSHV G protein-coupled receptor signals via multiple pathways to induce transcription factor activation in primary effusion lymphoma cells. Oncogene 23, 514-523.
21. Chambers, C. A., and Allison, J. P. (1999). Costimulatory regulation of T cell function. Curr. Opin. Cell Biol. 11,203-210.
22. Chatterjee, M., Osborne, J., Bestetti, G., Chang, Y., and Moore, P. S. (2002). Viral IL-6-induced cell proliferation and immune evasion of interferon activity. Science 298, 1432-1435.
23. Chaudhary, P. M., Jasmin, A., Eby, M. T., and Hood, L. (1999). Modulation of the NF-kappa B pathway by virally encoded death effector domains-containing proteins. Oncogene 18, 5738-5746.
24. Chen, D., Sandford, G., and Nicholas, J. (2009). Intracellular signaling mechanisms and activities of human herpesvirus 8 interleukin-6. J. Virol. 83, 722-733.
25. Chen, S., Bacon, K. B., Li, L., Garcia, G. E., Xia, Y., Lo, D., Thompson, D. A., Siani, M. A., Yamamoto, T., Harrison, J. K., and Feng, L. (1998). In vivo inhibition of CC and CX3C chemokine-induced leukocyte infiltration and attenuation of glomeru-lonephritis in Wistar-Kyoto (WKY) rats by vMIP-II. J. Exp. Med. 188, 193-198.
26. Chen, W., Hilton, I. B., Staudt, M. R., Burd, C. E., and Dittmer, D. P. (2010). Distinct p53, p53:LANA, and LANA complexes in Kaposi's sarcoma - associated herpesvirus lym-phomas. J. Virol. 84, 3898-3908.
27. Cheng, E. H., Nicholas, J., Bellows, D. S., Hayward, G. S., Guo, H. G., Reitz, M. S., and Hardwick, J. M. (1997). A Bcl-2 homolog encoded by Kaposi sarcoma-associated virus, human herpesvirus 8, inhibits apoptosis but does not heterodimerize with Bax or Bak. Proc. Natl. Acad. Sci. U.S.A. 94, 690-694.
28. Choi, Y. B., and Nicholas, J. (2008). Autocrine and paracrine promotion of cell survival and virus replication by human herpesvirus 8 chemokines. J. Virol. 82, 6501-6513.
29. Chow, D., He, X., Snow, A. L., Rose-John, S., and Garcia, K. C. (2001). Structure of an extracellular gp130 cytokine receptor signaling complex. Science 291, 2150-2155.
30. Chung, Y. H., Means, R. E., Choi, J. K., Lee, B. S., and Jung, J. U. (2002). Kaposi's sarcoma-associated herpesvirus OX2 glycoprotein activates myeloid-lineage cells to induce inflammatory cytokine production. J. Virol. 76, 4688-4698.
31. Cloutier, N., and Flamand, L. (2010). Kaposi sarcoma-associated herpesvirus latency-associated nuclear antigen inhibits interferon (IFN) beta expression by competing with IFN regulatory (factor)-3 for binding to IFNB promoter. J. Biol. Chem. 285, 7208-7221.
32. Collot-Teixeira, S., Bass, J., Denis, F., and Ranger-Rogez, S. (2004). Human tumor suppressor p53 and DNA viruses. Rev. Med. Virol. 14,301-319.
33. Coscoy, L. (2007). Immune evasion by Kaposi's sarcoma-associated herpesvirus. Nat. Rev. Immunol. 7, 391-401.
34. Coscoy, L., and Ganem, D. (2000). Kaposi's sarcoma-associated herpesvirus encodes two proteins that block cell surface display of MHC class I chains by enhancing their endocytosis. Proc. Natl. Acad. Sci. U.S.A. 97,8051-8056.
35. Coscoy, L., and Ganem, D. (2001). A viral protein that selectively down-regulates ICAM-1 and B7-2 and modulates T cell costimulation. J. Clin. Invest. 107, 1599-1606.
36. Coscoy, L., Sanchez, D. J., and Ganem, D. (2001). A novel class of herpesvirus -encoded membrane-bound E3 ubiq-uitin ligases regulates endocytosis of proteins involved in immune recognition.J. Cell Biol. 155, 1265-1273.
37. Cullen, B. R. (2009). Viral and cellular messenger RNA targets of viral microRNAs. Nature 457,421-425.
38. Cunningham, C., Barnard, S., Black-bourn, D. J., and Davison, A. J. (2003). Transcription mapping of human herpesvirus 8 genes encoding viral interferon regulatory factors.J. Gen. Virol. 84, 1471-1483.
39. Dalton-Griffin, L., Wilson, S. J., and Kel-lam, P. (2009). X-box binding protein 1 contributes to induction of the Kaposi's sarcoma-associated herpesvirus lytic cycle under hypoxic conditions. J. Virol. 83, 7202-7209.
40. Danial, N. N., and Korsmeyer, S. J. (2004). Cell death: critical control points. Cell 116,205-219.
41. Diehl, S., and Rincon, M. (2002). The two faces of IL-6 on Th1/Th2 differentiation. Mol. Immunol. 39, 531-536.
42. Dittmer, D., Lagunoff, M., Renne, R., Staskus, K., Haase, A., and Ganem, D.(1998). A cluster of latently expressed genes in Kaposi's sarcoma- associated herpesvirus. J. Virol. 72, 8309-8315.
43. Djerbi, M., Screpanti, V., Catrina, A. I., Bogen, B., Biberfeld, P., and Gran-dien, A. (1999). The inhibitor of death receptor signaling, FLICE-inhibitory protein defines anew class of tumor progression factors. J. Exp. Med. 190,1025-1032.
44. Dunkelberger, J. R., and Song, W. C. (2010). Complement and its role in innate and adaptive immune responses. Cell Res 20, 34-50.
45. Dustin, M. L., and Springer, T. A. (1989). T-cell receptor cross-linking transiently stimulates adhesiveness through LFA-1. Nature 341, 619-624.
46. Fakhari, F. D., and Dittmer, D. P. (2002). Charting latency transcripts in Kaposi's sarcoma-associated herpesvirus by whole-genome realtime quantitative PCR. J. Virol. 76, 6213-6223.
47. Feng, Z., Zhang, H., Levine, A. J., and Jin, S. (2005). The coordinate regulation of the p53 and mTOR pathways in cells. Proc. Natl. Acad. Sci. U.S.A. 102,8204-8209.
48. Field, N., Low, W., Daniels, M., How-ell, S., Daviet, L., Boshoff, C., and Collins, M. (2003). KSHV vFLIP binds to IKK-gamma to activate IKK. J. Cell. Sci. 116, 3721-3728.
49. Fodor, W. L., Rollins, S. A., Bianco-Caron, S., Rother, R. P., Guilmette, E. R., Burton, W. V., Albrecht, J. C., Fleckenstein, B., and Squinto, S. P. (1995). The complement con trol protein homolog of herpesvirus saimiri regulates serum complement by inhibiting C3 convertase activity. J. Virol. 69, 3889-3892.
50. Foster-Cuevas, M., Wright, G. J., Puklavec, M. J., Brown, M. H., and Barclay, A. N. (2004). Human herpesvirus 8 K14 protein mimics CD200 in down-regulating macrophage activation through CD200 receptor. J. Virol. 78, 7667-7676.
51. Foussat, A., Wijdenes, J., Bouchet, L., Gaidano, G., Neipel, F., Bal-abanian, K., Galanaud, P., Coud-erc, J., and Emilie, D. (1999). Human interleukin-6 is in vivo an autocrine growth factor for human herpesvirus-8-infected malignant B lymphocytes. Eur. CytokineNetw. 10, 501-508.
52. Friborg, J. Jr., Kong, W., Hottiger, M. O., and Nabel, G. J. (1999). p53 inhibition by the LANA protein of KSHV protects against cell death. Nature 402,889-894.
53. Fuld, S., Cunningham, C., Klucher, K., Davison, A. J., and Blackbourn, D. J. (2006). Inhibition of interferon signaling by the Kaposi's sarcoma-associated herpesvirus full-length viral interferon regulatory factor 2 protein. J. Virol. 80, 3092-3097.
54. Ganem, D., and Ziegelbauer, J. (2008). MicroRNAs of Kaposi's sarcoma-associated herpes virus. Semin. Cancer Biol. 18,437-440.
55. Gao, S. J., Boshoff, C., Jayachandra, S., Weiss, R. A., Chang, Y., and Moore, P. S. (1997). KSHV ORF K9 (vIRF) is an oncogene which inhibits the interferon signaling pathway. Oncogene 15, 1979-1985.
56. Goodbourn, S., Didcock, L., and Randall, R. E. (2000). Interferons: cell signalling, immune modulation, antiviral response and virus countermeasures. J. Gen. Virol. 81, 2341-2364.
57. Gottwein, E., Corcoran, D. L., Mukherjee, N., Skalsky, R. L., Hafner, M., Nusbaum, J. D., Shamulailatpam, P., Love, C. L., Dave, S. S., Tuschl, T., Ohler, U., and Cullen, B. R. (2011). Viral microRNA targetome of KSHV-infected primary effusion lymphoma cell lines. Cell Host Microbe 10,515-526.
58. Gottwein, E., and Cullen, B. R. (2010). A human herpesvirus microRNA inhibits p21 expression and attenuates p21 -mediated cell cycle arrest. J. Virol. 84, 5229-5237.
59. Gottwein, E., Mukherjee, N., Sachse, C., Frenzel, C., Majoros, W. H., Chi, J. T., Braich, R., Manoharan, M., Soutschek, J., Ohler, U., and Cullen, B.R. (2007).AviralmicroRNA functions as an orthologue of cellular miR-155. Nature 450, 1096-1099.
60. Green, D. R. (2005). Apoptotic pathways: ten minutes to dead. Cell 121, 671-674.
61. Gregory, S. M., Davis, B. K., West, J. A., Taxman, D. J., Matsuzawa, S., Reed, J. C., Ting, J. P., and Damania, B. (2011). Discovery of a viral NLR homolog that inhibits the inflammasome. Science 331, 330-334.
62. Gregory, S. M., West, J. A., Dillon, P. J., Hilscher, C., Dittmer, D. P., and Damania, B. (2009). Toll-like receptor signaling controls reactivation of KSHV from latency. Proc. Natl. Acad. Sci. U.S.A. 106,11725-11730.
63. Grossmann, C., Podgrabinska, S., Skobe, M., and Ganem, D. (2006). Activation of NF-kappaB by the latent vFLIP gene of Kaposi's sarcoma-associated herpesvirus is required for the spindle shape of virus-infected endothelial cells and contributes to their proinflammatory phenotype. J. Virol. 80, 7179-7185.
64. Harris, S. L., and Levine, A. J. (2005). The p53 pathway: positive and negative feedback loops. Oncogene 24, 2899-2908.
65. Hoischen, S. H., Vollmer, P., Marz, P., Ozbek, S., Gotze, K. S., Peschel, C., Jostock, T., Geib, T., Mullberg, J., Mechtersheimer, S., Fischer, M., Grötzinger, J., Galle, P. R., and Rose-John, S. (2000). Human herpes virus 8 interleukin-6 homologue triggers gp130 on neuronal and hematopoietic cells. Eur. J. Biochem. 267, 3604-3612.
66. Huang, Q., Petros, A. M., Virgin, H. W., Fesik, S. W., and Olejniczak, E. T. (2002). Solution structure of a Bcl-2 homolog from Kaposi sarcoma virus. Proc. Natl. Acad. Sci. U.S.A. 99, 3428-3433.
67. Inn, K. S., Lee, S. H., Rathbun, J. Y., Wong, L. Y., Toth, Z., Machida, K., Ou, J. H., and Jung, J. U. (2011). Inhibition of RIG-I-mediated signaling by Kaposi's sarcoma-associated herpesvirus-encoded deubiquitinase ORF64. J. Virol. 85, 10899-10904.
68. Iorio, M. V., Visone, R., Di Leva, G., Donati, V., Petrocca, F., Casalini, P., Taccioli, C., Volinia, S., Liu, C. G., Alder, H., Calin, G. A., Ménard, S., and Croce, C. M. (2007). MicroRNA signatures in human ovarian cancer. Cancer Res. 67, 8699-8707.
69. Ishido, S., Wang, C., Lee, B. S., Cohen, G. B., and Jung, J. U. (2000). Down-regulation of major histocompatibility complex class I molecules by Kaposi's sarcoma-associated herpesvirus K3 and K5 proteins. J. Virol. 74, 5300-5309.
70. Jia, B., Serra-Moreno, R., Neidermyer, W., Rahmberg, A., Mackey, J., Fofana, I. B., Johnson, W. E., Westmoreland, S., and Evans, D. T. (2009). Species-specific activity of SIV Nef and HIV-1 Vpu in overcoming restriction by tetherin/BST2. PLoS Pathog. 5, e1000429. doi:10.1371/journal.ppat.1000429
71. Joo, C. H., Shin, Y C, Gack, M., Wu, L., Levy, D., and Jung, J. U. (2007). Inhibition of interferon regulatory factor 7 (IRF7)-mediated interferon signal transduction by the Kaposi's sarcoma-associated herpesvirus viral IRF homolog vIRF3. J. Virol. 81,8282-8292.
72. Kaletsky, R. L., Francica, J. R., Agrawal-Gamse, C., and Bates, P. (2009). Tetherin-mediated restriction of filovirus budding is antagonized by the Ebola glycoprotein. Proc. Natl. Acad. Sci. U.S.A. 106,2886-2891.
73. Kapadia, S. B., Molina, H., van Berkel, V., Speck, S. H., and Virgin, H. W. T. (1999). Murine gammaherpesvirus 68 encodes a functional regulator of complement activation. J. Virol. 73, 7658-7670.
74. Kawai, T., and Akira, S. (2006). Innate immune recognition of viral infection. Nat. Immunol. 7,131-137.
75. Kim, H. J., Lee, S., and Jung, J. U. (2010). When autophagy meets viruses: a double-edged sword with functions in defense and offense. Semin. Immunopathol. 32, 323-341.
76. Lagos, D., Trotter, M. W., Vart, R. J., Wang, H. W., Matthews, N. C., Hansen, A., Flore, O., Gotch, F., and Boshoff, C. (2007). Kaposi sarcoma herpesvirus-encoded vFLIP and vIRF1 regulate antigen presentation in lymphatic endothelial cells. Blood 109, 1550-1558.
77. Lagos, D., Vart, R.J.,Gratrix,F.,Westrop, S. J., Emuss, V., Wong, P. P., Robey, R., Imami, N., Bower, M., Gotch, E, and Boshoff, C. (2008). Toll-like receptor 4 mediates innate immunity to Kaposi sarcoma herpesvirus. Cell Host Microbe 4,470-483.
78. Lamkanfi, M., and Dixit, V M. (2011). Modulation of inflamma-some pathways by bacterial and viral pathogens. J. Immunol. 187, 597-602.
79. Le Tortorec, A., and Neil, S. J. (2009). Antagonism to and intracellular sequestration of human tetherin by the human immunodeficiency virus type 2 envelope glycoprotein. J. Virol. 83,11966-11978.
80. Lee, H. R., Choi, W. C., Lee, S., Hwang, J., Hwang, E., Guchhait, K., Haas, J., Toth, Z., Jeon, Y. H., Oh, T. K., Kim, M. H., Jung, J. U. (2011). Bilateral inhibition of HAUSP deubiquitinase by a viral interferon regulatory factor protein. Nat. Struct. Mol. Biol. 18, 1336-1344.
81. Lee, H. R., Kim, M. H., Lee, J. S., Liang, C., and Jung, J. U. (2009). Viral interferon regulatory factors. J. Interferon CytokineRes. 29,621-627.
82. Lee, H. R., Toth, Z., Shin, Y. C., Lee, J. S., Chang, H., Gu, W., Oh, T. K., Kim, M. H., and Jung, J. U. (2009). Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor 4 targets MDM2 to deregulate the p53 tumor suppressor pathway. J. Virol. 83, 6739-6747.
83. Lee, J. S., Li, Q., Lee, J. Y., Lee, S. H., Jeong, J. H., Lee, H. R., Chang, H., Zhou, E C., Gao, S. J., Liang, C., and Jung, J. U. (2009). FLIP-mediated autophagy regulation in cell death control. Nat. Cell Biol. 11, 1355-1362.
84. Lee, H. R., Lee, S., Chaudhary, P. M., Gill, P., and Jung, J. U. (2010). Immune evasion by Kaposi's sarcoma-associated herpesvirus. Future Microbiol. 5, 1349-1365.
85. Lefort, S., Soucy-Faulkner, A., Grand-vaux, N., and Flamand, L. (2007). Binding of Kaposi's sarcoma-associated herpesvirus K-bZIP to interferon-responsive factor 3 elements modulates antiviral gene expression. J. Virol. 81, 10950-10960.
86. Lehner, P. J., Hoer, S., Dodd, R., and Duncan, L. M. (2005). Downregu-lation of cell surface receptors by the K3 family of viral and cellular ubiq-uitin E3 ligases. Immunol. Rev. 207, 112-125.
87. Lei, X., Bai, Z., Ye, F., Huang, Y., and Gao, S.J. (2010). Regulation of herpesvirus lifecycle by viral microR-NAs. Virulence 1, 433-435.
88. Lei, X., Bai, Z., Ye, F., Xie, J., Kim, C. G., Huang, Y., and Gao, S. J. (2010b). Regulation of NF-kappaB inhibitor IkappaBalpha and viral replication by a KSHV microRNA. Nat. Cell Biol. 12,193-199.
89. Levine, B. (2005). Eating oneself and uninvited guests: autophagy-related pathways in cellular defense. Cell 120,159-162.
90. Li, M., Damania, B., Alvarez, X., Ogryzko, V., Ozato, K., and Jung, J. U. (2000). Inhibition of p300 histone acetyltransferase by viral interferon regulatory factor. Mol. Cell. Biol. 20, 8254-8263.
91. Li, Q., Means, R., Lang, S., and Jung, J. U. (2007). Downregulation of gamma interferon receptor 1 by Kaposi's sarcoma-associated herpesvirus K3 andK5.J. Virol. 81,2117-2127.
92. Liang, C., Feng, P., Ku, B., Dotan, I., Canaani, D., Oh, B. H., and Jung, J. U. (2006). Autophagic and tumour suppressor activity of a novel Beclin1-binding protein UVRAG. Nat. Cell Biol. 8, 688-699.
93. Liang, C., and Jung, J. U. (2010). Autophagy genes as tumor suppressors. Curr. Opin. Cell Biol. 22, 226-233.
94. Liang, C., Lee, J. S., and Jung, J. U. (2008). Immune evasion in Kaposi's sarcoma-associated herpes virus associated oncogenesis. Semin. Cancer Biol. 18,423-436.
95. Lin, R., Genin, P., Mamane, Y., Sgar-banti, M., Battistini, A., Harrington, W. J. Jr., Barber, G. N., and Hiscott, J. (2001). HHV-8 encoded vIRF-1 represses the interferon antiviral response by blocking IRF-3 recruitment of the CBP/p300 coactivators. Oncogene 20, 800-811.
96. Lin, Y T., Kincaid, R. P., Arasappan, D., Dowd, S. E., Hunicke-Smith, S. P., and Sullivan, C. S. (2010). Small RNA profiling reveals anti-sense transcription throughout the KSHV genome and novel small RNAs. RNA 16, 1540-1558.
97. Liu, L., Eby, M. T., Rathore, N., Sinha, S. K., Kumar, A., and Chaudhary, P. M. (2002). The human herpes virus 8-encoded viral FLICE inhibitory protein physically associates with and persistently activates the Ikappa B kinase complex. J. Biol. Chem. 277, 13745-13751.
98. Loh, J., Huang, Q., Petros, A. M., Nettesheim, D., van Dyk, L. F., Labrada, L., Speck, S. H., Levine, B., Olejniczak, E. T., and Virgin, H. W. T. (2005). A surface groove essential for viral Bcl-2 function during chronic infection in vivo. PLoS Pathog. 1,e10. doi:10.1371/journal.ppat.0010010
99. Lu, F., Stedman, W., Yousef, M., Renne, R., and Lieberman, P. M. (2010). Epigenetic regulation of Kaposi's sarcoma-associated herpesvirus latency by virus-encoded microRNAs that target Rta and the cellular Rbl2-DNMT pathway. J. Virol. 84,2697-2706.
100. Lum, J. J., DeBerardinis, R. J., and Thompson, C.B. (2005). Autophagy in metazoans: cell survival in the land of plenty. Nat. Rev. Mol. Cell Biol. 6, 439-448.
101. Maiuri, M. C., Zalckvar, E., Kimchi, A., and Kroemer, G. (2007). Self-eating and self-killing: crosstalk between autophagy and apoptosis. Nat. Rev. Mol. Cell Biol. 8, 741-752.
102. Manes, T. D., Hoer, S., Muller, W. A., Lehner, P. J., and Pober, J. S. (2010). Kaposi's sarcoma-associated herpesvirus K3 and K5 proteins block distinct steps in transendothe-lial migration of effector memory CD4+ T cells by targeting different endothelial proteins. J. Immunol. 184,5186-5192.
103. Mansouri, M., Viswanathan, K., Douglas, J. L., Hines, J., Gustin, J., Moses, A. V., and Fruh, K. (2009). Molecular mechanism of BST2/tetherin down- regulation by K5/MIR2 of Kaposi's sarcoma-associated herpesvirus. J. Virol. 83,9672-9681.
104. Mark, L., Proctor, D. G., Blackbourn, D. J., Blom, A. M., and Spiller, O. B. (2008). Separation of decay- accelerating and cofactor functional activities of Kaposi's sarcoma- associated herpesvirus complement control protein using monoclonal antibodies. Immunology 123, 228-238.
105. Martin, D., Galisteo, R., Molinolo, A. A., Wetzker, R., Hirsch, E., and Gutkind, J. S. (2011). PI3Kgamma mediates Kaposi'ssarcoma-associated herpesvirus vGPCR-induced sar-comagenesis. Cancer Cell 19, 805-813.
106. Martinon, F., Burns, K., and Tschopp, J. (2002). The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol. Cell 10, 417-426.
107. Masood, R., Cai, J., Zheng, T., Smith, D. L., Naidu, Y., and Gill, P. S. (1997). Vascular endothelial growth factor/vascular permeability factor is an autocrine growth factor for AIDS-Kaposi sarcoma. Proc. Natl. Acad. Sci. U.S.A. 94, 979-984.
108. Masters, S. L., Simon, A., Aksentije-vich, I., and Kastner, D. L. (2009). Horror autoinflammaticus: the molecular pathophysiology of autoin-flammatory disease (*). Annu. Rev. Immunol. 27, 621-668.
109. Meads, M. B., and Medveczky, P. G. (2004). Kaposi's sarcoma-associated herpesvirus-encoded viral interleukin-6 is secreted and modified differently than human interleukin-6: evidence for a unique autocrine signaling mechanism. J. Biol. Chem. 279, 51793-51803.
110. Miao, E. A., Leaf, I. A., Treuting, P. M., Mao, D. P., Dors, M., Sarkar, A., Warren, S. E., Wewers, M. D., and Aderem, A. (2010). Caspase-1-induced pyroptosis is an innate immune effector mechanism against intracellular bacteria. Nat. Immunol. 11,1136-1142.
111. Michael, D., and Oren, M. (2003). The p53-Mdm2 module and the ubiqui-tin system. Semin. Cancer Biol. 13, 49-58.
112. Micheletti, F., Monini, P., Fortini, C., Rimessi, P., Bazzaro, M., Andreoni, M., Giuliani, M., Traniello, S., Ensoli, B., and Gavioli, R. (2002). Identification of cytotoxic T lymphocyte epitopes of human herpesvirus 8. Immunology 106, 395-403.
113. Mills, K. R., Reginato, M., Debnath, J., Queenan, B., and Brugge, J. S. (2004). Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is required for induction of autophagy during lumen formation in vitro. Proc. Natl. Acad. Sci. U.S.A. 101,3438-3443.
114. Molden, J., Chang, Y., You, Y., Moore, P. S., and Goldsmith, M. A. (1997). A Kaposi's sarcoma-associated herpesvirus-encodedcytokine homolog (vIL-6) activates signaling through the shared gp130 receptor subunit. J. Biol. Chem. 272, 19625-19631.
115. Montaner, S. (2007). Akt/TSC/mTOR activation by the KSHV G protein-coupled receptor: emerging insights into the molecular oncogenesis and treatment of Kaposi's sarcoma. Cell Cycle 6, 438-443.
116. Montaner, S., Sodhi, A., Molinolo, A., Bugge, T. H., Sawai, E. T., He, Y., Li, Y., Ray, P. E., and Gutkind, J. S. (2003). Endothelial infection with KSHV genes in vivo reveals that vGPCR initiates Kaposi's sarcoma-genesis and can promote the tumori-genic potential of viral latent genes. Cancer Cell 3,23-36.
117. Montaner, S., Sodhi, A., Servitja, J. M., Ramsdell, A. K., Barac, A., Sawai, E. T., and Gutkind, J. S. (2004). The small GTPase Rac1 links the Kaposi sarcoma-associated her-pesvirus vGPCR to cytokine secretion and paracrine neoplasia. Blood 104,2903-2911.
118. Moore, P. S., Boshoff, C., Weiss, R. A., and Chang, Y. (1996). Molecular mimicry of human cytokine and cytokine response pathway genes by KSHV. Science 274, 1739-1744.
119. Morgan, B. P., Marchbank, K. J., Longhi, M. P., Harris, C. L., and Gallimore, A. M. (2005). Complement: central to innate immunity and bridging to adaptive responses. Immunol Lett. 97,171-179.
120. Mori, Y., Nishimoto, N., Ohno, M., Inagi, R., Dhepakson, P., Amou, K., Yoshizaki, K., and Yamanishi, K. (2000). Human herpesvirus 8-encoded interleukin-6 homologue (viral IL-6) induces endogenous human IL-6 secretion. J. Med. Virol. 61,332-335.
121. Mutocheluh, M., Hindle, L., Areste, C., Chanas, S. A., Butler, L. M., Lowry, K., Shah, K., Evans, D. J., and Blackbourn, D. J. (2011). Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor-2 inhibits type 1 interferon signalling by targeting interferon-stimulated gene factor-3. J. Gen. Virol. 92,2394-2398.
122. Nachmani, D., Stern-Ginossar, N., Sarid, R., and Mandelboim, O. (2009). Diverse herpesvirus microRNAs target the stress-induced immune lig-and MICB to escape recognition by natural killer cells. Cell Host Microbe 5,376-385.
123. Nakamura, H., Li, M., Zarycki, J., and Jung, J. U. (2001). Inhibition of p53 tumor suppressor by viral interferon regulatory factor. J. Virol. 75, 7572-7582.
124. Nakamura, S., Murakami-Mori, K., Rao, N., Weich, H. A., and Rajeev, B. (1997). Vascular endothelial growth factor is apotent angiogenic factor in AIDS-associated Kaposi's sarcoma-derived spindle cells. J. Immunol. 158,4992-5001.
125. Nathan, J. A., and Lehner, P. J. (2009). The trafficking and regulation of membrane receptors by the RING-CH ubiquitin E3 ligases. Exp. Cell Res. 315, 1593-1600.
126. Neil, S. J., Zang, T., and Bieniasz, P. D. (2008). Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu. Nature 451,425-430.
127. Okroj, M., Mark, L., Stokowska, A., Wong, S. W., Rose, N., Blackbourn, D. J., Villoutreix, B. O., Spiller, O. B., and Blom, A. M. (2009). Characterization of the complement inhibitory function of rhesus rhadi-novirus complement control protein (RCP). J. Biol. Chem. 284, 505-514.
128. O'Neill, L. A., and Bowie, A. G. (2010). Sensing and signaling in antiviral innate immunity. Curr. Biol. 20, R328-R333.
129. Pardieu, C., Vigan, R., Wilson, S. J., Calvi, A., Zang, T., Bieniasz, P., Kel-lam, P., Towers, G. J., and Neil, S. J. (2010). The RING-CH lig-ase K5 antagonizes restriction of KSHV and HIV-1 particle release by mediating ubiquitin-dependent endosomal degradation of tetherin. PLoS Pathog. 6, e1000843. doi:10.1371/journal.ppat.1000843
130. Pattingre,S.,Tassa,A.,Qu,X.,Garuti,R., Liang, X. H., Mizushima, N., Packer, M., Schneider, M. D., and Levine, B. (2005). Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy. Cell 122, 927-939.
131. Paulose-Murphy, M., Ha, N. K., Xiang, C., Chen, Y., Gillim, L., Yarchoan, R., Meltzer, P., Bittner, M., Trent, J., and Zeichner, S. (2001). Transcription program of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus). J. Virol. 75, 4843-4853.
132. Pestka, S., Krause, C. D., and Walter, M. R. (2004). Interferons, interferon-like cytokines, and their receptors. Immunol. Rev. 202, 8-32.
133. Pfeffer, S., Zavolan, M., Grasser, F. A., Chien, M., Russo, J. J., Ju, J., John, B., Enright, A. J., Marks, D., Sander, C., and Tuschl, T. (2004). Identification of virus-encoded microRNAs. Science 304, 734-736.
134. Pyo, J. O., Jang, M. H., Kwon, Y K., Lee, H. J., Jun, J. I., Woo, H. N., Cho, D. H., Choi, B., Lee, H., Kim, J. H., Mizushima, N., Oshumi, Y., and Jung, Y.K. (2005). Essential roles of Atg5 and FADD in autophagic cell death: dissection of autophagic cell death into vacuole formation and cell death. J. Biol. Chem. 280, 20722-20729.
135. Qin, Z., Freitas, E., Sullivan, R., Mohan, S., Bacelieri, R., Branch, D., Romano, M., Kearney, P., Oates, J., Plaisance, K., Renne, R., Kaleeba, J., and Parsons, C. (2010). Upregulation of xCT by KSHV-encoded microRNAs facilitates KSHV dissemination and persistence in an environment of oxida-tive stress. PLoS Pathog. 6, e1000742. doi:10.1371/journal.ppat.1000742
136. Reimold, A. M., Ponath, P. D., Li, Y. S., Hardy, R. R., David, C. S., Strominger, J. L., and Glimcher, L. H. (1996). Transcription factor B cell lineage-specific activator protein regulates the gene for human X-box binding protein 1. J. Exp. Med. 183, 393-401.
137. Rezaee, S. A., Gracie, J. A., McInnes, I. B., and Blackbourn, D. J. (2005). Inhibition of neutrophil function by the Kaposi's sarcoma-associated herpesvirus vOX2 protein. AIDS 19, 1907-1910.
138. Rivas, C., Thlick, A. E., Parravicini, C., Moore, P. S., and Chang, Y. (2001). Kaposi's sarcoma-associated herpesvirus LANA2 is a B-cell-specific latent viral protein that inhibits p53. J. Virol. 75, 429-438.
139. Sadler, A. J., and Williams, B. R. (2008). Interferon-inducible antiviral effectors. Nat. Rev. Immunol. 8, 559-568.
140. Salata, C., Curtarello, M., Calistri, A., Sartori, E., Sette, P., de Bernard, M., Parolin, C., and Palu, G. (2009). vOX2 glycoprotein of human herpesvirus 8 modulates human primary macrophages activity. J. Cell. Physiol. 219, 698-706.
141. Samols, M. A., Skalsky, R. L., Mal-donado, A. M., Riva, A., Lopez, M. C., Baker, H. V., and Renne, R. (2007). Identification of cellular genes targeted by KSHV-encoded microRNAs. PLoS Pathog. 3, e65. doi:10.1371/journal.ppat.0030065
142. Sanchez, D. J., Coscoy, L., and Ganem, D. (2002). Functional organization of MIR2, a novel viral regulator of selective endocytosis. J. Biol. Chem. 277,6124-6130.
143. Sarid, R., Sato, T., Bohenzky, R. A., Russo, J. J., and Chang, Y. (1997). Kaposi's sarcoma-associated herpesvirus encodes a functional bcl-2 homologue. Nat. Med. 3, 293-298.
144. Schmidt, K., Wies, E., and Neipel, F. (2011). Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor 3 inhibits gamma interferon and major histocompatibility complex class II expression. J. Virol. 85,4530-4537.
145. Schroder, K., and Tschopp, J. (2010). The inflammasomes. Cell 140, 821-832.
146. Seo, T., Park, J., Lee, D., Hwang, S. G., and Choe, J. (2001). Viral interferon regulatory factor 1 of Kaposi's sarcoma-associated herpesvirus binds to p53 and represses p53-dependent transcription and apoptosis. J. Virol. 75, 6193-6198.
147. Shin, Y C, Nakamura, H., Liang, X., Feng, P., Chang, H., Kowalik, T. F., and Jung, J. U. (2006). Inhibition of the ATM/p53 signal transduc-tion pathway by Kaposi's sarcoma-associated herpesvirus interferon regulatory factor 1. J. Virol. 80, 2257-2266.
148. Shiratori, I., Yamaguchi, M., Suzukawa, M., Yamamoto, K., Lanier, L. L., Saito, T., and Arase, H. (2005). Down-regulation of basophil function by human CD200 and human herpesvirus-8 CD200. J. Immunol. 175,4441-4449.
149. Si, H., and Robertson, E. S. (2006). Kaposi'ssarcoma-associated herpesvirus-encodedlatency-associated nuclear antigen induces chromosomal instability through inhibition of p53 function. J. Virol. 80, 697-709.
150. Skalsky, R. L., Samols, M. A., Plaisance, K. B., Boss, I. W., Riva, A., Lopez, M. C., Baker, H. V., and Renne, R. (2007). Kaposi's sarcoma-associated herpesvirus encodes an ortholog of miR-155. J. Virol. 81, 12836-12845.
151. Sodhi, A., Montaner, S., Patel, V., Zohar, M., Bais, C., Mesri, E. A., and Gutkind, J. S. (2000). The Kaposi's sarcoma-associated herpes virus G protein-coupled receptor up-regulates vascular endothelial growth factor expression and secretion through mitogen-activated protein kinase and p38 pathways acting on hypoxia-inducible factor 1alpha. Cancer Res. 60, 4873-4880.
152. Sperling, A. I., and Bluestone, J. A. (1996). The complexities of T-cell co-stimulation: CD28 and beyond. Immunol. Rev. 153, 155-182.
153. Spiller, O. B., Blackbourn, D. J., Mark, L., Proctor, D. G., and Blom, A. M. (2003). Functional activity of the complement regulator encoded by Kaposi's sarcoma-associated herpesvirus. J. Biol. Chem. 278, 9283-9289.
154. Spiller, O. B., Robinson, M., O'Donnell, E., Milligan, S., Morgan, B. P., Davison, A. J., and Blackbourn, D. J. (2003). Complement regulation by Kaposi's sarcoma-associated herpesvirus ORF4 protein. J. Virol. 77, 592-599.
155. Spiller, O. B., Mark, L., Blue, C. E., Proctor, D. G., Aitken, J. A., Blom, A. M., and Blackbourn, D. J. (2006). Dissecting the regions of virion-associated Kaposi's sarcoma-associated herpesvirus complement control protein required for complement regulation and cell binding. J. Virol. 80,4068-4078.
156. Sun, Q., Matta, H., Lu, G., and Chaud-hary, P. M. (2006). Induction of IL-8 expression by human herpesvirus 8 encoded vFLIP K13 via NF-kappaB activation. Oncogene 25,2717-2726.
157. Suzuki, T., Isobe, T., Kitagawa, M., and Ueda, K. (2010). Kaposi's sarcoma-associated herpesvirus-encoded LANA positively affects on ubiquitylation of p53. Biochem. Biophys. Res. Commun. 403,194-197.
158. Swanton, C., Mann, D. J., Fleckenstein, B., Neipel, F., Peters, G., and Jones, N. (1997). Herpes viral cyclin/Cdk6 complexes evade inhibition by CDK inhibitor proteins. Nature 390,184-187.
159. Takaoka, A., Tamura, T., and Taniguchi, T. (2008). Interferon regulatory factor family of transcription factors and regulation of oncogenesis. Cancer Sci. 99,467-478.
160. Tamura, T., Yanai, H., Savitsky, D., and Taniguchi, T. (2008). The IRF family transcription factors in immunity and oncogenesis. Annu. Rev. Immunol. 26, 535-584.
161. Thorburn, J., Moore, F., Rao, A., Barclay, W. W., Thomas, L. R., Grant, K. W., Cramer, S. D., and Thorburn, A. (2005). Selective inactivation of a Fas-associated death domain protein (FADD)-dependent apoptosis and autophagy pathway in immortal epithelial cells. Mol. Biol. Cell 16, 1189-1199.
162. Ting, J. P., Willingham, S. B., and Bergstralh, D. T. (2008). NLRs at the intersection of cell death and immunity. Nat. Rev. Immunol. 8, 372-379.
163. Trinchieri, G. (2010). Type I interferon: friend or foe? J. Exp. Med. 207, 2053-2063.
164. Umbach, J. L., and Cullen, B. R. (2010). In-depth analysis of Kaposi's sarcoma-associated herpesvirus microRNA expression provides insights into the mammalian microRNA-processing machinery. J. Virol. 84, 695-703.
165. Van Damme, N., Goff, D., Katsura, C., Jorgenson, R. L., Mitchell, R., Johnson, M. C., Stephens, E. B., and Guatelli, J. (2008). The interferon-induced protein BST-2 restricts HIV-1 release and is downregulated from the cell surface by the viral Vpu protein. Cell Host Microbe 3, 245-252.
166. Vogelstein, B., Lane, D., and Levine, A. J. (2000). Surfing the p53 network. Nature 408, 307-310.
167. Wang, X., Lybarger, L., Connors, R., Harris, M. R., and Hansen, T. H. (2004). Model for the interaction of gammaherpesvirus 68 RING-CH finger protein mK3 with major histocompatibility complex class I and the peptide-loading complex. J. Virol. 78, 8673-8686.
168. Weber, K. S., Grone, H. J., Rocken, M., Klier, C., Gu, S., Wank, R., Proud-foot, A. E., Nelson, P. J., and Weber, C. (2001). Selective recruitment of Th2-type cells and evasion from a cytotoxic immune response mediated by viral macrophage inhibitory protein-II. Eur. J. Immunol. 31, 2458-2466.
169. West, J., and Damania, B. (2008). Upregulation of the TLR3 pathway by Kaposi's sarcoma-associated herpesvirus during primary infection. J. Virol. 82, 5440-5449.
170. West, J. A., Gregory, S. M., Sivaraman, V., Su, L., and Damania, B. (2011). Activation of plasmacytoid dendritic cells by Kaposi's sarcoma-associated herpesvirus. J. Virol. 85, 895-904.
171. Wies, E., Hahn, A. S., Schmidt, K., Viebahn, C., Rohland, N., Lux, A., Schellhorn, T., Holzer, A., Jung, J. U., and Neipel, E (2009). The Kaposi's sarcoma-associated herpesvirus-encoded vIRF-3 inhibits cellular IRF-5.J. Biol. Chem. 284,8525-8538.
172. Wilson, S. J., Tsao, E. H., Webb, B. L., Ye, H., Dalton-Griffin, L., Tsan-toulas, C., Gale, C. V., Du, M. Q., Whitehouse, A., and Kellam, P. (2007). X box binding protein XBP-1s transactivates the Kaposi's sarcoma-associated herpesvirus (KSHV) ORF50 promoter, linking plasma cell differentiation to KSHV reactivation from latency. J. Virol. 81,13578-13586.
173. Ye, E C., Zhou, E C., Xie, J. P., Kang, T., Greene, W., Kuhne, K., Lei, X. E, Li, Q. H., and Gao, S. J. (2008). Kaposi's sarcoma-associated herpesvirus latent gene vFLIP inhibits viral lytic replication through NF-kappaB-mediated suppression of the AP-1 pathway: a novel mechanism of virus control of latency. J. Virol. 82, 4235-4249.
174. Yu, F., Feng, J., Harada, J. N., Chanda, S. K., Kenney, S. C., and Sun, R. (2007). B cell terminal differentiation factor XBP-1 induces reactivation of Kaposi's sarcoma-associated herpesvirus. FEBS Lett. 581,3485-3488.
175. Yu, Y., and Hayward, G. S. (2010). The ubiquitin E3 ligase RAUL negatively regulates type i interferon through ubiquitination of the transcription factors IRF7 andIRF3. Immunity 33, 863-877.
176. Yu, Y., Wang, S. E., and Hayward, G. S. (2005). The KSHV immediate-early transcription factor RTA encodes ubiquitin E3 ligase activity that targets IRF7 for proteosome-mediated degradation. Immunity 22, 59-70.
177. Zhang, F., Wilson, S. J., Landford, W. C., Virgen, B., Gregory, D., Johnson, M. C., Munch, J., Kirchhoff, F., Bieniasz, P. D., and Hatziioannou, T. (2009). Nef proteins from simian immunodeficiency viruses are teth-erin antagonists. Cell Host Microbe 6, 54-67.
178. Zhao, J., Punj, V., Matta, H., Mazzacu-rati, L., Schamus, S., Yang, Y., Yang, T., Hong, Y., and Chaudhary, P. M. (2007). K13 blocks KSHV lytic replication and deregulates vIL6 and hIL6 expression: a model of lytic replication induced clonal selection in viral oncogenesis. PLoS ONE 2, e1067. doi:10.1371/journal.pone.0001067
179. Zhu, E X., King, S. M., Smith, E. J., Levy, D. E., and Yuan, Y. (2002). A Kaposi's sarcoma-associated herpesviral protein inhibits virus-mediated induction of type I interferon by blocking IRF-7 phosphoryla-tion and nuclear accumulation. Proc. Natl. Acad. Sci. U.S.A. 99, 5573-5578.
180. Ziegelbauer, J. M. (2011). Functions of Kaposi's sarcoma-associated herpesvirusmicroRNAs. Biochim. Biophys. Acta 1809, 623-630.
181. Ziegelbauer, J. M., Sullivan, C. S., and Ganem, D. (2009). Tandem array-based expression screens identify host mRNA targets of virus-encoded microRNAs. Nat. Genet. 41, 130-134.
182. Zimring, J. C., Goodbourn, S., and Offermann, M. K. (1998). Human herpesvirus 8 encodes an interferon regulatory factor (IRF) homolog that represses IRF-1-mediated transcription.J. Virol. 72, 701-707.